Institutional Ownership Pliant Therapeutics, Inc. (PLRX)
This table provides information about the institutional ownership of Pliant Therapeutics, Inc. (PLRX). We have compiled data on the 175 institutions that hold shares in the stock, with a total of 64.8 Million shares, which have been reported (via 13F filing form) to have a value of $195 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
5,972,257
shares
|
$18.4 Million
3.46% of portfolio
|
Q2 2024
Added 3.87%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,971,639
shares
|
$15.3 Million
0.0% of portfolio
|
Q2 2024
Added 6.79%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
4,634,486
shares
|
$14.3 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.14%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,228,755
shares
|
$9.94 Million
0.0% of portfolio
|
Q4 2024
Reduced 8.44%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,197,050
shares
|
$9.85 Million
1.61% of portfolio
|
Q4 2024
Added 2.98%
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
3,014,199
shares
|
$9.28 Million
25.76% of portfolio
|
Q3 2023
Reduced 3.3%
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,895,478
shares
|
$8.92 Million
2.98% of portfolio
|
Q4 2024
Reduced 9.45%
|
|
Blue Owl Capital Holdings LP
New York, NY |
Feb 14, 2025 Q4 2024 |
2,769,199
shares
|
$8.53 Million
15.59% of portfolio
|
Q4 2024
Reduced 7.82%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
2,551,865
shares
|
$7.86 Million
0.01% of portfolio
|
Q4 2024
Added 66.31%
|
|
Trv Gp Iv, LLC
Boston, MA |
Feb 13, 2025 Q4 2024 |
2,132,867
shares
|
$6.57 Million
35.03% of portfolio
|
Q2 2020
New holding
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
2,015,000
shares
|
$6.21 Million
0.16% of portfolio
|
Q4 2023
Added 21.02%
|
|
First Light Asset Management, LLC
Edina, MN |
Feb 14, 2025 Q4 2024 |
1,681,110
shares
|
$5.18 Million
2.16% of portfolio
|
Q4 2024
Reduced 34.73%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,385,236
shares
|
$4.27 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.25%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,316,648
shares
|
$4.06 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.13%
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
1,315,601
shares
|
$4.05 Million
4.17% of portfolio
|
Q4 2024
New holding
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,281,000
shares
|
$3.95 Million
0.27% of portfolio
|
Q2 2024
New holding
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,266,030
shares
|
$3.9 Million
0.02% of portfolio
|
Q4 2024
Reduced 1.07%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,120,803
shares
|
$3.45 Million
0.89% of portfolio
|
Q4 2024
New holding
|
|
Great Point Partners LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,055,000
shares
|
$3.25 Million
9.16% of portfolio
|
Q4 2024
Reduced 44.77%
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
1,045,577
shares
|
$3.22 Million
0.0% of portfolio
|
Q4 2024
Added 0.55%
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
900,104
shares
|
$2.77 Million
0.07% of portfolio
|
Q4 2024
Added 8.03%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
782,004
shares
|
$2.41 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.3%
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
750,000
shares
|
$2.31 Million
1.3% of portfolio
|
Q4 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
649,660
shares
|
$2 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
639,808
shares
|
$1.97 Million
0.01% of portfolio
|
Q2 2023
New holding
|